CSCI (CSCI) News
Follow CSCI (CSCI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
COSCIENS Issues About $12M in 15% Convertible Debentures
COSCIENS issued about $12 million of unsecured convertible debentures toward a maximum offering of $20 million. The company plans to market the offering through mid-November; conversion is subject to shareholder approval
EQUITY | Oct 19, 2026, 12:04 PM UTC
L
Cosciens Biopharma to make up to four earn-out payments
MACRO | Sep 10, 2026, 08:17 PM UTC
L
Cosciens acquires Nualtis Corp
MNA | Sep 10, 2026, 08:15 PM UTC
L
COSCIENS Biopharma Inc. Completes Share Capital Amendment
TORONTO, ONTARIO, July 03, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma I
EQUITY | Jul 03, 2026, 12:30 PM UTC